The Pharmacology of Calcium Channel Antagonists: a Novel Class of Anti‐migraine Agents?
- 1 November 1983
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 23 (6) , 278-283
- https://doi.org/10.1111/j.1526-4610.1983.hed2306278.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The current neurologic burden of illness and injury in the United StatesNeurology, 1982
- Spreading Cerebral Oligemia in Classical‐ and Normal Cerebral Blood Flow in Common MigraineHeadache: The Journal of Head and Face Pain, 1982
- A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in MigraineHeadache: The Journal of Head and Face Pain, 1981
- Sources of activator calcium in rabbit basilar arteryAmerican Journal of Physiology-Heart and Circulatory Physiology, 1981
- The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.Circulation Research, 1981
- Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteriesEuropean Journal of Pharmacology, 1981
- The Biochemistry of MigraineHeadache: The Journal of Head and Face Pain, 1980
- Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries.Stroke, 1980
- MULTIPLE SEROTONIN RECEPTORS - DIFFERENTIAL BINDING OF [5-HYDROXYTRYPTAMINE-H-3, [LYSERGIC-H-3 ACID DIETHYLAMIDE AND [H-3]SPIROPERIDOL1979